Experimental Research on the Effect of Ginsenoside Rb1 in Curing Rats with Spinal Cord Ischemia-reperfusion Injury

Spinal cord ischemia-reperfusion injury (SCII), which was proposed by Allen in 1911, is the secondary damage of primary spinal cord injury and the main reason resulting in nerve injury complication and sequela (1). Ginsenoside is one of the ingredients of Ginseng and the monomer composition being purified at present reached over 50 types(2-3). The existing research proves that Ginsenoside Rb1 can play a significant role in neuro protection by alleviating oxygen radical generated from brain injury and lowering calcium influx. In this way, cerebral ischemia-reperfusion injury can be alleviated, but few researches are found in terms of s pinal cord ischemia-reperfusion injury(4-6).